HPGDS and cancer: However, it is essential to note that in these cancers, tumor cells can develop resistance to cisplatin for a variety of reasons, including reduced cisplatin (DDP) levels in the cell, increased glutathione and glutathione S-transferase activity, accumulation of metallothionein’s in the cell, and improved DNA repair (136).